5 completed, 1 terminated, 1 unknown, 1 withdrawn. 8 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 5, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Fondaparinux: new trials by email Literature Review of Fondaparinux trials Research Report on Fondaparinux
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 Tirofiban Injection, Clopidogrel, Acetylsalicylic acid - Pneumonia, Viral, Corona Virus Infection | Phase 2 | Completed | University of Milan | 5 | 2020-04-06 | 2020-04-29 |
| Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm fondaparinux, unfractionated heparin, Vitamin-K-Antagonist - Fibrillation, Atrial | Phase 2 | Completed | GlaxoSmithKline | 349 | 2009-08-01 | 2012-10-01 |
| Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures Nadroparin, Fondaparinux - Deep Vein Thrombosis, Pulmonary Embolism | Phase 2 / Phase 3 | Unknown | Red Cross Hospital Beverwijk | 669 | 2009-04-01 | 2012-12-18 |
| The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients fondaparinux sodium, sequential compression devices - Venous Thromboembolism | Phase 2 / Phase 3 | Completed | Mary Knudson, M.D. | 105 | 2007-12-01 | 2013-12-24 |
| Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT) fondaparinux, warfarin - Heparin-Induced Thrombocytopenia | Phase 2 | Terminated | University of Louisville | 3 | 2007-11-01 | 2019-11-08 |
| Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers Fondaparinux Sodium - Venous Thrombosis, Pulmonary Embolism | Phase 2 | Completed | University of Pittsburgh | 21 | 2007-02-01 | 2008-05-16 |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer fondaparinux sodium - Cervical Cancer, Endometrial Cancer | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 44 | 2007-01-01 | 2017-12-28 |
| A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN) fondaparinux sodium, heparin, percutaneous coronary intervention (PCI) - Myocardial Infarction, Coronary Disease | Phase 2 | Withdrawn | Schering-Plough | 300 | 2003-04-01 | 2009-11-03 |
Pulmonary Embolism (3) · Venous Thrombosis (3) · Thrombosis (2) · Acute Coronary Syndrome (1) · Ankle Fractures (1) · Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · COVID-19 (1) · Carcinoma, Ovarian Epithelial (1) · Cardiovascular Diseases (1) · Coronary Disease (1) · Coronavirus Infections (1) · Embolism and Thrombosis (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1)
GlaxoSmithKline (1) · Mary Knudson, M.D. (1) · Masonic Cancer Center, University of Minnesota (1) · Red Cross Hospital Beverwijk (1) · Schering-Plough (1) · University of Louisville (1) · University of Milan (1) · University of Pittsburgh (1)
United States (5) · France (2) · Canada (1) · Germany (1) · Italy (1) · Netherlands (1)
Goetz H Kloecker, MD, MSPH (1) · Ioannis Raftopoulos, MD, PhD (1) · Levi S. Downs, MD (1) · M. Margaret Knudson, MD (1) · Roelf S Breederveld, MD, PhD (1) · Yannick M Groutars, MD (1)